SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-22-001123
Filing Date
2022-09-16
Accepted
2022-09-16 16:34:46
Documents
13
Period of Report
2022-09-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT nhwk_8k.htm   iXBRL 8-K 57609
  Complete submission text file 0001079973-22-001123.txt   275823

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nhwk-20220915.xsd EX-101.SCH 3739
3 XBRL DEFINITION FILE nhwk-20220915_def.xml EX-101.DEF 26569
4 XBRL LABEL FILE nhwk-20220915_lab.xml EX-101.LAB 36527
5 XBRL PRESENTATION FILE nhwk-20220915_pre.xml EX-101.PRE 25193
7 EXTRACTED XBRL INSTANCE DOCUMENT nhwk_8k_htm.xml XML 5277
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 221248501
SIC: 2834 Pharmaceutical Preparations